Epilepsy is treatable and treatment simpler with advanced technology, says experts

Image
ANI Kochi [India]
Last Updated : Nov 05 2016 | 6:02 PM IST

With advancement in healthcare, epilepsy is eminently treatable now. Nearly 70% of patients who are initiated to the advanced treatment, as a result of latest technology, become free of seizures or epileptic fits within 1 to 2 years and in about half of them, the drugs can be tapered off in due course.

Neurosurgeons from across the world deliberated the latest technological advancement in treating persons with epilepsy. From mapping brain deficiencies to localising the deficiencies and surgically correcting it without affecting the complex areas around, neurosurgery has come of age, with advanced mapping devices, technological assistants to carry out surgery with optimum precision.

Advanced functional Magnetic Resonating Imaging, PET scan or positron emission tomography scan, QEEG or quantitative electroencephalograph to identify areas of over or under-activity of brain, Extra-operative Intracranial EEG(ICEEG) to monitor progress of treatment, Stereo-EEG to monitor the electric activity on the surface and deep inside the brain are some of the new-age machines that help make treatment of epilepsy more advanced with optimum results at reduced cost.

International experts - Dr. Dileep Nair, Head of Adult Epilepsy and Dr. Imad Najm, Director Epilepsy Centre from the Cleveland Clinic, USA, Dr. Richard Wennberg, Director, Clinical Neurophysiology and national experts like Dr. K. Radhakrishnan former Director of the Sree Chitra Tirunal Institute for Medical Sciences and Technology and present Director of Amrita Advanced Centre for Epilepsy, Dr. Malla Bhaskar Rao of NIMHANS spoke on the efficacy of various treatment protocols for epilepsy.

India has one-sixth of the global burden of epilepsy, with 12 out of every 1000 people affected and an annual increase of six per every ten thousand Indians. Of the 70 million persons with epilepsy worldwide, nearly 12 million are estimated to be in India.

Ironically, almost 90% of people with epilepsy in India do not receive any treatment. Lack of knowledge of anti-epileptic drugs, poverty, cultural beliefs, stigma, poor health infrastructure and shortage of trained professionals contribute to the treatment gap. There are not more than 20 centers in the country that are capable of treating drug resistant epilepsies.

The international and national experts will also perform advanced techniques hands on at the Amrita Advanced Centre for Epilepsy, which is one of the advanced centers in the country for treatment of this neurological disorder.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 05 2016 | 6:02 PM IST

Next Story